title: Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).
abstract: OBJECTIVE
  To study optical coherence tomographic (OCT) results and vision at 6 months after transition (post-Tx) from intravitreal bevacizumab and/or ranibizumab to aflibercept for treatment of neovascular age-related macular degeneration (nAMD). The null hypothesis was the lack of improvements in OCT metrics and vision outcome in study eyes at 6 months after transitioning from bevacizumab or ranibizumab to aflibercept.
  
  
  METHODS
  This retrospective study assessed 6 monthly OCT (Cirrus) data after transitioning to aflibercept for eyes on prior Legacy-ranibizumab, Legacy-bevacizumab, or mixed treatment for nAMD. Outcome measures were subretinal fluid (SRF), cystoid macular edema (CME), pigment epithelial detachment (PED) heights and volumes, central 1- and 3-mm subfield, Macular Volume, and best spectacle and pinhole visual acuity (VA). A single masked investigator performed all OCT measurements.
  
  
  RESULTS
  One hundred eighty-nine eyes in 172 patients in Legacy-bevacizumab (95 eyes), Legacy-ranibizumab (84 eyes), or Mixed Group(10 eyes) were switched to aflibercept and followed for 6 months. Significant post-Tx reductions were noted in SRF/CME heights and volumes (all P<.001). Similar findings were noted for PED heights (122.8 μm vs 79.4 μm) and PED volumes (all P<.001). Post-Tx VA was better (20/43 vs 20/51, P<.001). There were no differences between Legacy-bevacizumab and Legacy-ranibizumab groups in OCT and VA changes. Post-Tx VA, SRF/CME, and PED heights and volumes were improved for Nonresponders (suboptimal response to bevacizumab/ranibizumab) (P=.001 to <.001), but not Responders (good responses to same). The only adverse event was a retinal pigment epithelial tear in one eye.
  
  
  CONCLUSIONS
  Significant improvements in vision and OCT metrics developed in Nonresponders but not in Responders. Post-Tx VA and OCT measures were similar for eyes on prior bevacizumab or ranibizumab. Post-Tx adverse events were uncommon.
authors: Southern California Desert Retina Consultants, Palm Desert, California, and Loma Linda University, Loma Linda, California.
authors: Clement K
authors: CK
authors: Chan
authors: San Diego Retina Associates, San Diego, California.
authors: Atul
authors: A
authors: Jain
authors: Doheny Eye Institute, Los Angeles, California and.
authors: Srinivas
authors: S
authors: Sadda
authors: Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, California.
authors: Neeta
authors: N
authors: Varshney
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D057915:Drug Substitution; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D008268:Macular Degeneration / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D000069579:Ranibizumab; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012189:Retrospective Studies; D041623:Tomography, Optical Coherence; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D011993:Recombinant Fusion Proteins; C533178:aflibercept; D000068258:Bevacizumab; D040262:Receptors, Vascular Endothelial Growth Factor; D000069579:Ranibizumab
references: Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18751-6
references: 19841260
references: Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1132-42
references: 16538452
references: Ophthalmology. 2012 Dec;119(12):2537-48
references: 23084240
references: Am J Ophthalmol. 2002 Jan;133(1):168-9
references: 11755871
references: Br J Ophthalmol. 2013 Jul;97(7):917-23
references: 23686000
references: N Engl J Med. 1994 Dec 1;331(22):1480-7
references: 7526212
references: Br J Ophthalmol. 2014 Dec;98(12):1636-41
references: 25001321
references: Clin Ophthalmol. 2013;7:615-20
references: 23569354
references: Arch Ophthalmol. 1990 Oct;108(10):1442-7
references: 1699513
references: Angiogenesis. 2012 Jun;15(2):171-85
references: 22302382
references: Ophthalmology. 2006 Jun;113(6):992-1001.e6
references: 16647134
references: Arch Ophthalmol. 1990 Jun;108(6):825-31
references: 1693497
references: Drugs Today (Barc). 2012 May;48(5):317-29
references: 22645720
references: Am J Ophthalmol. 2006 Dec;142(6):1068-70
references: 17157597
references: Ophthalmology. 2009 Oct;116(10 Suppl):S1-7
references: 19800534
references: Am J Ophthalmol. 2011 May;151(5):887-895.e1
references: 21310390
references: Am J Ophthalmol. 2010 Sep;150(3):315-324.e1
references: 20598667
references: Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11393-8
references: 12177445
references: Biochem Biophys Res Commun. 1989 Jun 15;161(2):851-8
references: 2735925
references: Ophthalmologe. 1998 Oct;95(10):725-31
references: 9828641
references: Expert Rev Clin Pharmacol. 2013 Mar;6(2):103-13
references: 23473589
references: Graefes Arch Clin Exp Ophthalmol. 1998 May;236(5):365-74
references: 9602321
references: Am J Ophthalmol. 2009 Jul;148(1):43-58.e1
references: 19376495
references: Ophthalmology. 2012 Jun;119(6):1175-83
references: 22306121
references: Am J Ophthalmol. 2003 Feb;135(2):169-77
references: 12566020
references: Am J Ophthalmol. 2006 Jul;142(1):160-2
references: 16815269
references: Arch Ophthalmol. 1999 Sep;117(9):1161-73
references: 10496388
references: Curr Med Res Opin. 2012 Mar;28(3):395-400
references: 22283373
references: Drugs Aging. 2012 Oct;29(10):839-46
references: 23038609
references: Am J Ophthalmol. 2001 May;131(5):541-60
references: 11336929
references: Br J Ophthalmol. 2006 Sep;90(9):1207-8
references: 16929069
references: Eye (Lond). 2008 Dec;22(12):1504-7
references: 18535608
references: Eur J Ophthalmol. 2007 Nov-Dec;17(6):992-5
references: 18050131
references: Retina. 2007 Nov-Dec;27(9):1196-200
references: 18046224
references: J Ocul Pharmacol Ther. 2012 Dec;28(6):581-8
references: 22775078
references: Immunotherapy. 2013 Feb;5(2):121-30
references: 23413903
references: Retina. 2001;21(6):661-5
references: 11756893
references: Graefes Arch Clin Exp Ophthalmol. 2002 Jul;240(7):533-8
references: 12136282
references: Ophthalmologe. 2014 Aug;111(8):775-7
references: 24062151
references: Ophthalmology. 2011 Dec;118(12):2447-52
references: 21872935
references: Retina. 2010 Oct;30(9):1368-75
references: 20517175
references: Arch Ophthalmol. 2000 Mar;118(3):327-36
references: 10721954
references: Arch Ophthalmol. 1999 Sep;117(9):1177-87
references: 10496389
references: Am J Ophthalmol. 2001 Apr;131(4):518-20
references: 11292425
references: Arch Ophthalmol. 1994 Apr;112(4):500-9
references: 7512336
references: Clin Ophthalmol. 2013;7:1287-9
references: 23836958
references: Toxicol Pathol. 1999 Sep-Oct;27(5):536-44
references: 10528633
references: N Engl J Med. 2006 Oct 5;355(14 ):1432-44
references: 17021319
references: Am J Ophthalmol. 2013 Mar;155(3):429-437.e7
references: 23218699
references: Br J Ophthalmol. 2012 Sep;96(9):1157-8
references: 22446028
references: Expert Opin Pharmacother. 2005 Jul;6(8):1421-3
references: 16013991
references: Ophthalmology. 2007 Mar;114(3):525-36
references: 17123615
references: Expert Opin Drug Saf. 2004 Jul;3(4):345-61
references: 15268651
references: Ophthalmology. 2011 Feb;118(2):345-52
references: 20926135
references: Am J Ophthalmol. 2006 Apr;141(4):752-4
references: 16564819
references: Retina. 2007 Jun;27(5):523-34
references: 17558312
references: Ophthalmologe. 2008 Feb;105(2):158-64
references: 17653552
references: Retina. 2012 Mar;32(3):434-57
references: 22374154
references: Am J Ophthalmol. 2013 Jul;156(1):15-22.e1
references: 23706500
references: Ophthalmology. 2009 Mar;116(3):504-12
references: 19167078
references: Ophthalmology. 2007 Dec;114(12):2179-82
references: 18054637
references: Retina. 2007 Jun;27(5):541-51
references: 17558314
references: Drugs. 2005;65(11):1571-7; discussion 1578-9
references: 16033295
references: Retina. 2007 Sep;27(7):857-63
references: 17891009
references: Control Clin Trials. 1984 Sep;5(3):203-16
references: 6488805
references: Nat Rev Drug Discov. 2012 Mar 30;11(4):269-70
references: 22460118
references: Indian J Ophthalmol. 2007 Nov-Dec;55(6):470-2
references: 17951911
references: Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3158-64
references: 10967078
references: Retina. 2002 Dec;22(6):759-67
references: 12476103
references: Retina. 2007 Jun;27(5):535-40
references: 17558313
references: Curr Drug Targets. 2011 Feb;12(2):173-81
references: 20887245
references: Am J Ophthalmol. 1984 Sep 15;98(3):376-7
references: 6540994
references: Arch Ophthalmol. 1990 Jun;108(6):816-24
references: 1693496
references: Retina. 2013 Oct;33(9):1735-62
references: 23873168
references: Eur J Ophthalmol. 2011 Jan-Feb;21(1):73-6
references: 20623466
references: J Biol Chem. 1992 Dec 25;267(36):26031-7
references: 1464614
references: Retina. 2002 Oct;22(5):669-71
references: 12441742
references: Retina. 2011 Sep;31(8):1449-69
references: 21817960
references: Br J Ophthalmol. 2012 Oct;96(10 ):1351-4
references: 22872673
references: Am J Ophthalmol. 1988 Mar 15;105(3):285-90
references: 2449819
references: Klin Monbl Augenheilkd. 1998 Dec;213(6):aA11-5
references: 10048006
references: Invest Ophthalmol Vis Sci. 2000 Mar;41(3):624-8
references: 10711673
references: Retina. 2009 Nov-Dec;29(10):1424-31
references: 19898180
references: Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):336-9
references: 16156153
references: Arch Ophthalmol. 2004 Apr;122(4):564-72
references: 15078675
references: Clin Ther. 2006 Jan;28(1):36-44
references: 16490578
references: Nat Med. 2003 Jun;9(6):669-76
references: 12778165
references: Arch Ophthalmol. 2006 May;124(5):660-4
references: 16682587
references: Retina. 2008 Oct;28(9):1265-9
references: 18628724
references: Br J Ophthalmol. 2004 Sep;88(9):1173-9
references: 15317711
references: Retina. 2002 Feb;22(1):6-18
references: 11884872
references: Arch Ophthalmol. 2002 Mar;120(3):338-46
references: 11879138
references: Ophthalmology. 2014 Jan;121(1):202-8
references: 24084497
references: Am J Ophthalmol. 2007 Aug;144(2):281-3
references: 17659955
references: Mol Vis. 2012;18:830-7
references: 22511846
references: Retina. 2006 Oct;26(8):859-70
references: 17031284
references: Ophthalmology. 1989 Oct;96(10):1526-34
references: 2479899
references: Am J Ophthalmol. 2012 Aug;154(2):222-6
references: 22813448
references: N Engl J Med. 2004 Dec 30;351(27):2805-16
references: 15625332
references: Science. 1983 Feb 25;219(4587):983-5
references: 6823562
references: Am J Ophthalmol. 2013 Jul;156(1):23-28.e2
references: 23664153
references: Am J Ophthalmol. 2005 Aug;140(2):251-5
references: 15992756
references: Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7792-8
references: 21862646
references: Expert Opin Biol Ther. 2012 Oct;12(10):1299-313
references: 22866908
references: Ann Epidemiol. 2008 Aug;18(8):647-56
references: 18652983
references: Am J Epidemiol. 1993 Jan 15;137(2):190-200
references: 8452123
references: N Engl J Med. 2011 May 19;364(20):1897-908
references: 21526923
references: Am J Ophthalmol. 2001 Jan;131(1):50-4
references: 11162979
references: Am J Ophthalmol. 2006 Dec;142(6):1070-2
references: 17157598
references: Am J Ophthalmol. 2007 Apr;143(4):566-83
references: 17386270
references: Arch Ophthalmol. 1986 May;104(5):694-701
references: 2423061
references: Arch Ophthalmol. 1999 Oct;117(10 ):1400-2
references: 10532450
references: Eye (Lond). 2008 Jun;22(6):761-7
references: 18388961
references: Ophthalmology. 2006 Sep;113(9):1508.e1-25
references: 16828500
references: Arch Ophthalmol. 1991 Aug;109(8):1109-14
references: 1714270
references: Invest Ophthalmol Vis Sci. 2003 May;44(5):2141-6
references: 12714654
references: Arch Ophthalmol. 1995 Aug;113(8):1019-29
references: 7639652
references: Retina. 2013 Sep;33(8):1605-12
references: 23549101
references: Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4605-10
references: 11274374
references: Ophthalmology. 2002 May;109(5):920-7
references: 11986098
references: N Engl J Med. 2006 Oct 5;355(14):1419-31
references: 17021318
references: Issues Emerg Health Technol. 2005 Dec;(76):1-4
references: 16544440
references: Arch Ophthalmol. 2010 Oct;128(10):1273-9
references: 20937996
references: Ophthalmologica. 2012;228(2):78-83
references: 22710369
references: Arch Ophthalmol. 1993 Sep;111(9):1200-9
references: 7689827
references: Ophthalmology. 2012 Aug;119(8):1658-65
references: 22537617
references: Arch Ophthalmol. 1989 Mar;107(3):344-52
references: 2466454
references: Retina. 2005 Oct-Nov;25(7):815-27
references: 16205558
references: Am J Health Syst Pharm. 2012 Jan 1;69(1):6
references: 22180543
references: Eur J Ophthalmol. 2007 Jul-Aug;17(4):674-6
references: 17671950
references: Surv Ophthalmol. 2000 Nov-Dec;45(3):195-214
references: 11094244
references: Dev Ophthalmol. 2010;46:21-38
references: 20703030
references: Eye (Lond). 2011 Sep;25(9):1181-6
references: 21701525
references: Klin Monbl Augenheilkd. 2007 Apr;224(4):297-9
references: 17458796
references: Curr Vasc Pharmacol. 2011 Sep;9(5):629-46
references: 21470108
references: JAMA Ophthalmol. 2013 Feb;131(2):260-2
references: 23411901
references: Nature. 2000 Sep 14;407(6801):242-8
references: 11001067
references: J Clin Invest. 1989 Nov;84(5):1470-8
references: 2478587
references: Biochem Biophys Res Commun. 2011 May 6;408(2):276-81
references: 21501594
references: Invest Ophthalmol Vis Sci. 2010 May;51(5):2388-92
references: 20007836
references: Arch Ophthalmol. 1986 Apr;104(4):503-12
references: 2420315
references: Arch Ophthalmol. 1999 Oct;117(10 ):1329-45
references: 10532441
references: Br J Ophthalmol. 2008 May;92(5):667-8
references: 18356264
references: Ophthalmology. 2011 Sep;118(9):1819-26
references: 21546089
references: Eye (Lond). 2013 May;27(5):663-7; quiz 668
references: 23558214
references: Curr Opin Ophthalmol. 2013 May;24(3):190-6
references: 23492430
references: Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5899-903
references: 21685343
references: Am J Ophthalmol. 2005 Aug;140(2):200-6
references: 15992752
references: Arch Ophthalmol. 1990 Jun;108(6):832-7
references: 1693498
references: Ophthalmology. 2013 May;120(5 Suppl):S23-5
references: 23642783
references: Arch Ophthalmol. 2002 Nov;120(11):1443-54
references: 12427056
references: Retina. 1989;9(3):163-9
references: 2480626
references: Eye (Lond). 2005 Dec;19(12):1315-24
references: 15803179
references: Ophthalmology. 2011 Jun;118(6):1098-106
references: 21640258
references: Clin Ophthalmol. 2008 Dec;2(4):727-33
references: 19668423
references: Arch Ophthalmol. 1984 Nov;102(11):1640-2
references: 6208888
references: Exp Eye Res. 2007 Oct;85(4):425-30
references: 17714704
references: Ophthalmology. 2007 May;114(5):855-9
references: 17467524
references: Am J Ophthalmol. 2007 Mar;143(3):504-5
references: 17317395
references: Ophthalmology. 2011 Mar;118(3):523-30
references: 20920825
references: Br J Ophthalmol. 2005 Jul;89(7):864-70
references: 15965168
references: Retina. 2010 Jul-Aug;30(7):1046-50
references: 20559157
references: Am J Ophthalmol. 2006 Feb;141(2):396-398
references: 16458709
references: J Mol Biol. 1999 Nov 5;293(4):865-81
references: 10543973
references: Br J Ophthalmol. 2006 Nov;90(11):1344-9
references: 16854824
references: Eye (Lond). 2008 Jan;22(1):82-6
references: 17891059
references: Retina. 2013 May;33(5):1056-61
references: 23266881
references: Arch Ophthalmol. 2009 Sep;127(9):1101-14
references: 19752419
references: Ophthalmologica. 2012;227 Suppl 1:11-20
references: 22517121
references: Am J Ophthalmol. 2013 Jul;156(1):29-35.e2
references: 23668679
references: Surv Ophthalmol. 2011 Mar-Apr;56(2):95-113
references: 21335144
references: Arch Ophthalmol. 1984 Nov;102(11):1583
references: 6208887
references: Ophthalmology. 2011 Jun;118(6):1089-97
references: 21640257
references: Clin Exp Ophthalmol. 2008 Apr;36(3):252-6
references: 18412594
references: Am J Ophthalmol. 2007 Mar;143(3):505-7
references: 17317396
references: Ophthalmology. 2012 Jul;119(7):1388-98
references: 22555112
references: Arch Ophthalmol. 1987 Nov;105(11):1499-507
references: 2445326
references: Am J Ophthalmol. 1994 Oct 15;118(4):445-50
references: 7943121
references: Mayo Clin Proc. 2012 Jan;87(1):77-88
references: 22212972
references: Arch Ophthalmol. 2001 Feb;119(2):198-207
references: 11176980
references: Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):331-5
references: 16156152
references: Exp Eye Res. 2006 Sep;83(3):615-9
references: 16678158
references: Drugs Today (Barc). 2005 Nov;41(11):703-9
references: 16395411
references: Eye (Lond). 2008 Jun;22(6):792-8
references: 17585313
references: Health Technol Assess. 2012;16(6):i-xii, 1-200
references: 22348600
references: Am J Ophthalmol. 2004 Apr;137(4):683-96
references: 15059708
references: Arch Ophthalmol. 2009 Sep;127(9):1115-28
references: 19752420